Does daily co-administration of letrozole and gonadotropins during ovarian stimulation improve IVF outcome?
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1477-7827
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Does daily co-administration of letrozole and gonadotropins during ovarian stimulation improve IVF outcome? ; volume:15 ; number:1 ; day:30 ; month:8 ; year:2017 ; pages:1-5 ; date:12.2017
Reproductive biology and endocrinology ; 15, Heft 1 (30.8.2017), 1-5, 12.2017
- Schlagwort
-
Gynäkologie
Frauenkrankheit
- Urheber
-
Haas, Jigal
- Beteiligte Personen und Organisationen
-
Bassil, Rawad
Meriano, Jim
Samara, Nivin
Barzilay, Eran
Gonen, Noa
Casper, Robert F.
SpringerLink (Online service)
- DOI
-
10.1186/s12958-017-0288-8
- URN
-
urn:nbn:de:1111-2017110812175
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:39 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Haas, Jigal
- Bassil, Rawad
- Meriano, Jim
- Samara, Nivin
- Barzilay, Eran
- Gonen, Noa
- Casper, Robert F.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Monitoring of controlled ovarian stimulation in IVF
Does daily co administration of gonadotropins and letrozole during the ovarian stimulation improve IVF outcome for poor and sub optimal responders?
Letrozole supplementation during controlled ovarian stimulation in expected high responders: a pilot randomized controlled study
Mild ovarian stimulation with letrozole plus fixed dose human menopausal gonadotropin prior to IVF/ICSI for infertile non-obese women with polycystic ovarian syndrome being pre-treated with metformin: a pilot study
Hormonal, follicular and endometrial dynamics in letrozole-treated versus natural cycles in patients undergoing controlled ovarian stimulation
Predicting IVF outcome in poor ovarian responders
Progestin Primed Ovarian Stimulation (PPOS) protocol yields lower euploidy rate in older patients undergoing IVF
Impact of letrozole co-treatment in an antagonist protocol for IVF/ICSI: a retrospective study
BRCA1 mutation carriers have a lower number of mature oocytes after ovarian stimulation for IVF/PGD
Stop GnRH-agonist/GnRH-antagonist protocol: a different insight on ovarian stimulation for IVF
Predictive factors for ovarian response in a corifollitropin alfa/GnRH antagonist protocol for controlled ovarian stimulation in IVF/ICSI cycles
Letrozole co-treatment in an antagonist protocol for overweight women undergoing IVF treatment: a retrospective study
Monitoring of controlled ovarian stimulation in IVF
Does daily co administration of gonadotropins and letrozole during the ovarian stimulation improve IVF outcome for poor and sub optimal responders?
Letrozole supplementation during controlled ovarian stimulation in expected high responders: a pilot randomized controlled study
Mild ovarian stimulation with letrozole plus fixed dose human menopausal gonadotropin prior to IVF/ICSI for infertile non-obese women with polycystic ovarian syndrome being pre-treated with metformin: a pilot study
Hormonal, follicular and endometrial dynamics in letrozole-treated versus natural cycles in patients undergoing controlled ovarian stimulation
Predicting IVF outcome in poor ovarian responders
Progestin Primed Ovarian Stimulation (PPOS) protocol yields lower euploidy rate in older patients undergoing IVF
Impact of letrozole co-treatment in an antagonist protocol for IVF/ICSI: a retrospective study
BRCA1 mutation carriers have a lower number of mature oocytes after ovarian stimulation for IVF/PGD
Stop GnRH-agonist/GnRH-antagonist protocol: a different insight on ovarian stimulation for IVF
Predictive factors for ovarian response in a corifollitropin alfa/GnRH antagonist protocol for controlled ovarian stimulation in IVF/ICSI cycles
Letrozole co-treatment in an antagonist protocol for overweight women undergoing IVF treatment: a retrospective study
Monitoring of controlled ovarian stimulation in IVF
Does daily co administration of gonadotropins and letrozole during the ovarian stimulation improve IVF outcome for poor and sub optimal responders?
Letrozole supplementation during controlled ovarian stimulation in expected high responders: a pilot randomized controlled study
Mild ovarian stimulation with letrozole plus fixed dose human menopausal gonadotropin prior to IVF/ICSI for infertile non-obese women with polycystic ovarian syndrome being pre-treated with metformin: a pilot study
Hormonal, follicular and endometrial dynamics in letrozole-treated versus natural cycles in patients undergoing controlled ovarian stimulation
Predicting IVF outcome in poor ovarian responders
Progestin Primed Ovarian Stimulation (PPOS) protocol yields lower euploidy rate in older patients undergoing IVF
Impact of letrozole co-treatment in an antagonist protocol for IVF/ICSI: a retrospective study
BRCA1 mutation carriers have a lower number of mature oocytes after ovarian stimulation for IVF/PGD
Stop GnRH-agonist/GnRH-antagonist protocol: a different insight on ovarian stimulation for IVF
Predictive factors for ovarian response in a corifollitropin alfa/GnRH antagonist protocol for controlled ovarian stimulation in IVF/ICSI cycles